70 related articles for article (PubMed ID: 11802202)
1. Clinical role of MMP-2/TIMP-2 imbalance in hepatocellular carcinoma.
Giannelli G; Bergamini C; Marinosci F; Fransvea E; Quaranta M; Lupo L; Schiraldi O; Antonaci S
Int J Cancer; 2002 Feb; 97(4):425-31. PubMed ID: 11802202
[TBL] [Abstract][Full Text] [Related]
2. Redox Biomarkers and Matrix Remodeling Molecules in Ovarian Cancer.
Supruniuk E; Baczewska M; Żebrowska E; Maciejczyk M; Lauko KK; Dajnowicz-Brzezik P; Milewska P; Knapp P; Zalewska A; Chabowski A
Antioxidants (Basel); 2024 Feb; 13(2):. PubMed ID: 38397798
[TBL] [Abstract][Full Text] [Related]
3. Urinary biomarkers for hepatocellular carcinoma: current knowledge for clinicians.
Deng K; Xing J; Xu G; Jin B; Wan X; Zheng Y; Du S; Sang X
Cancer Cell Int; 2023 Oct; 23(1):239. PubMed ID: 37833757
[TBL] [Abstract][Full Text] [Related]
4. Exosomal proteomics identifies RAB13 as a potential regulator of metastasis for HCC.
Huang XY; Zhang JT; Li F; Li TT; Shi XJ; Huang J; Huang XY; Zhou J; Tang ZY; Huang ZL
Hepatol Commun; 2023 Jan; 7(1):e0006. PubMed ID: 36633475
[TBL] [Abstract][Full Text] [Related]
5. Knock down of TIMP-2 by siRNA and CRISPR/Cas9 mediates diverse cellular reprogramming of metastasis and chemosensitivity in ovarian cancer.
Escalona RM; Chu S; Kadife E; Kelly JK; Kannourakis G; Findlay JK; Ahmed N
Cancer Cell Int; 2022 Dec; 22(1):422. PubMed ID: 36585738
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B Viral Protein HBx and the Molecular Mechanisms Modulating the Hallmarks of Hepatocellular Carcinoma: A Comprehensive Review.
Sivasudhan E; Blake N; Lu Z; Meng J; Rong R
Cells; 2022 Feb; 11(4):. PubMed ID: 35203390
[TBL] [Abstract][Full Text] [Related]
7. Expression of TIMPs and MMPs in Ovarian Tumors, Ascites, Ascites-Derived Cells, and Cancer Cell Lines: Characteristic Modulatory Response Before and After Chemotherapy Treatment.
Escalona RM; Kannourakis G; Findlay JK; Ahmed N
Front Oncol; 2021; 11():796588. PubMed ID: 35047406
[TBL] [Abstract][Full Text] [Related]
8. TIMP-2 regulates 5-Fu resistance via the ERK/MAPK signaling pathway in colorectal cancer.
Zhang G; Luo X; Wang Z; Xu J; Zhang W; Chen E; Meng Q; Wang D; Huang X; Zhou W; Song Z
Aging (Albany NY); 2022 Jan; 14(1):297-315. PubMed ID: 35022331
[TBL] [Abstract][Full Text] [Related]
9. Zinc Administration and Improved Serum Markers of Hepatic Fibrosis in Patients with Autoimmune Hepatitis.
Moriya K; Nishimura N; Namisaki T; Takaya H; Sawada Y; Kawaratani H; Kaji K; Shimozato N; Sato S; Furukawa M; Douhara A; Akahane T; Mitoro A; Yamao J; Yoshiji H
J Clin Med; 2021 Jun; 10(11):. PubMed ID: 34199421
[TBL] [Abstract][Full Text] [Related]
10. Angiogenesis-related non-coding RNAs and gastrointestinal cancer.
Razavi ZS; Asgarpour K; Mahjoubin-Tehran M; Rasouli S; Khan H; Shahrzad MK; Hamblin MR; Mirzaei H
Mol Ther Oncolytics; 2021 Jun; 21():220-241. PubMed ID: 34095461
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional Profiling of Porcine HCC Xenografts Provides Insights Into Tumor Cell Microenvironment Signaling.
Patel SS; Sandur A; El-Kebir M; Gaba RC; Schook LB; Schachtschneider KM
Front Genet; 2021; 12():657330. PubMed ID: 33995488
[TBL] [Abstract][Full Text] [Related]
12. The Epigenetic Regulation of Microenvironment in Hepatocellular Carcinoma.
Wang F; Malnassy G; Qiu W
Front Oncol; 2021; 11():653037. PubMed ID: 33791228
[TBL] [Abstract][Full Text] [Related]
13. Analysis and Validation of Human Targets and Treatments Using a Hepatocellular Carcinoma-Immune Humanized Mouse Model.
Zhao Y; Wang J; Liu WN; Fong SY; Shuen TWH; Liu M; Harden S; Tan SY; Cheng JY; Tan WWS; Chan JKY; Chee CE; Lee GH; Toh HC; Lim SG; Wan Y; Chen Q
Hepatology; 2021 Sep; 74(3):1395-1410. PubMed ID: 33738839
[TBL] [Abstract][Full Text] [Related]
14. Molecular Mechanisms to Target Cellular Senescence in Hepatocellular Carcinoma.
Mittermeier C; Konopa A; Muehlich S
Cells; 2020 Nov; 9(12):. PubMed ID: 33255630
[TBL] [Abstract][Full Text] [Related]
15. An Iatrogenic Model of Brain Small-Vessel Disease: Post-Radiation Encephalopathy.
Moretti R; Caruso P
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899565
[TBL] [Abstract][Full Text] [Related]
16. Selected Matrix Metalloproteinases (MMP-2, MMP-7) and Their Inhibitor (TIMP-2) in Adult and Pediatric Cancer.
Kaczorowska A; Miękus N; Stefanowicz J; Adamkiewicz-Drożyńska E
Diagnostics (Basel); 2020 Jul; 10(8):. PubMed ID: 32751899
[TBL] [Abstract][Full Text] [Related]
17. Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics.
Raeeszadeh-Sarmazdeh M; Do LD; Hritz BG
Cells; 2020 May; 9(5):. PubMed ID: 32466129
[TBL] [Abstract][Full Text] [Related]
18. Matrix Metalloproteinases as Potential Biomarkers and Therapeutic Targets in Liver Diseases.
Geervliet E; Bansal R
Cells; 2020 May; 9(5):. PubMed ID: 32414178
[TBL] [Abstract][Full Text] [Related]
19. The Role of Matrix Metalloproteinases in the Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma.
Scheau C; Badarau IA; Costache R; Caruntu C; Mihai GL; Didilescu AC; Constantin C; Neagu M
Anal Cell Pathol (Amst); 2019; 2019():9423907. PubMed ID: 31886121
[TBL] [Abstract][Full Text] [Related]
20. Mebendazole augments sensitivity to sorafenib by targeting MAPK and BCL-2 signalling in n-nitrosodiethylamine-induced murine hepatocellular carcinoma.
Younis NS; Ghanim AMH; Saber S
Sci Rep; 2019 Dec; 9(1):19095. PubMed ID: 31836811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
